Literature DB >> 16236975

Pneumothorax-associated pleural eosinophilia in mice is interleukin-5 but not interleukin-13 dependent.

Ioannis Kalomenidis1, Yubiao Guo, R Stokes Peebles, Kirk B Lane, Spyros Papiris, Jack Elias, Richard W Light.   

Abstract

STUDY
OBJECTIVES: To establish a murine model of pneumothorax-associated pleural eosinophilia and to examine the role of interleukin (IL)-5 and IL-13 in the pathogenesis of this reaction.
DESIGN: An animal study.
INTERVENTIONS: One hundred thirty-seven C57/Bl-6 mice were used in this study. Wild-type animals were injected intrapleurally with 0.4 mL of air and were killed at different time points (30 min to 7 days) after the injection. IL-5 knockout and IL-13 knockout animals were killed 24 h and 48 h after the injection. Pleural inflammation was assessed by pleural lavage (PL). MEASUREMENTS AND
RESULTS: PL cells were significantly increased following the induction of pneumothorax. The peak number of neutrophils, observed at 12 h, was 900 times higher than the control. The peak number of eosinophils, observed at 48 h, was 700 times higher than the control. Lymphocytes and mononuclear cells increased threefold and fourfold, respectively. IL-5 knockout mice had significantly less PL eosinophils than that the wild-type or the IL-13 knockout mice at 24 h (150 +/- 46/microL, 903 +/- 244/microL, and 912 +/- 168/microL, respectively; p = 0.013) and 48 h (181 +/- 45/microL, 1,587 +/- 212/microL, and 1,379 +/- 364/microL, respectively; p = 0.003).
CONCLUSION: Pneumothorax induces an inflammatory reaction of the mouse pleura, mainly characterized by increased neutrophils and eosinophils. IL-5 but not IL-13 is required for pneumothorax-associated pleural eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236975     DOI: 10.1378/chest.128.4.2978

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  1 in total

1.  Recurrent post-traumatic non-eosinophilic pleural effusion: report of three cases.

Authors:  Artur Eugênio de Azevedo Pereira; Ricardo Mingarini Terra; Lisete Ribeiro Teixeira; Paulo Manuel Pêgo-Fernandes; Fábio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.